baber/WOPTO huggingface dataset:
Patent NZ-507085-A (NZ)
Title: Maturation of somatic embryos in a medium comprising a gelling agent and a porous support which reduces the availability of water in the growth environment
Inventor: SUTTON BENJAMIN C S
IPC: A01H4/00
Filed: 1998-08-14
Abstract: A method of developing and maturing somatic embryos in a growth environment, which method comprises manipulating the water availability of the growth environment using a physical means of control which is a porous support or a gelling agent in the growth medium.
Patent NZ-509838-A (NZ)
Title: Lubricating oil compositions containing rust preventing agent and an antiwear agent
Inventor: BABA YOSHIHARU
IPC: C10N40/08
Filed: 1999-08-18
Abstract: A lubricating oil composition comprises (I) 100 parts by weight of a base oil for a lubricating oil, (II) an antiwear agent, and (III) a rust preventing agent, The antiwear agent comprises: (i)  from  0.05 to 10 parts by weight of a phosphorothionate of  formula  (1) and from 0.01 to 1.0 part by weight  of  an amine salt of a phosphorus compound of formula (2a) and/or (ii) from 0.05 to 10 parts by weight of a dithiophosphate of formula (3a). The  rust preventing agent comprises from 0.01 to 1.0  parts by  weight of a polyalkylene polyamide obtained by  reacting (a)  a  polyalkylene polyamine of formula (4a),  and  (b)  a carboxylic acid having from 4 to 30 carbon atoms. Formula (I) is S=P(-O-R1)3 wherein R1 is an alkyl and/or  an aryl group. Formula  (2a)  is  X=P(XR2)2 XH wherein X is sulphur  and/or oxygen and R2 is alkyl and/or aryl. Formula (3a) is S=P(OR6)2 (-S-A') wherein R6 is alkyl and/or aryl  group and A' is a hydrocarbon group optionally further containing one or more oxygen atoms. Formula  (4a)  is  R11(R12)-N  R10-NR13)mH  wherein  R10  is alkylene;   R11,  R12  and  R13 are independently  hydrogen, alkyl and/or a hydroxyalkyl and m is 1 to 10.
Patent NZ-511661-A (NZ)
Title: An improved aerofoil
Inventor: GROVE GRAHAM BOND
IPC: B64C21/04
Filed: 2001-05-11
Abstract: An aerofoil is disclosed which is adjustable between  a high  profile  configuration for subsonic  flow  and  a  low profile  configuration for supersonic flow and  including  a leading  edge  (10) which generates a subsonic leading  edge breakaway flow in the high profile configuration,  an  upper surface  (13)  having a leading portion inclined  away  from the  leading  edge, a lower surface (12),  a  trailing  edge (11),  and  at least one opening provided along the  leading portion  of  the upper surface and arranged to  discharge  a sufficient volume of gas away from the leading edge (10)  to assist  in  reattachment of the leading edge breakaway  flow to the upper surface (13).
Patent NZ-512862-A (NZ)
Title: Lock with removable core
Inventor: WIDEN BO
IPC: E05B9/08
Filed: 2000-01-21
Abstract: A removable core cylinder lock, comprising a casing (10) with a cavity (11), a lock core (20) insertable into said cavity, a cylindrical, rotatable key plug (60) located in a bore in said core, and a retainer member, which is transversely movable in the lock core (20) between a first, locking position and a second, releasing position. The casing has an inwardly protruding locking projection (12) which engages with an axially limited recess (50) in the retainer member when the latter is located in the first, locking position.
Patent NZ-515182-A (NZ)
Title: Extraction of biologically active compounds from plant material using acid and antioxidant
Inventor: GREENE JOHN BERTRAM
IPC: A61K36/82
Filed: 2001-10-31
Abstract: Disclosed are methods of extraction of biologically active compounds from a botanical material including the steps of: A) Reducing the particle size of the botanical material, preferable down to a size of 0.1mm to 50mm in length, B) Mixing the botanical material with a solution containing water, an acid compound and an antioxidant compound, wherein the acid and antioxidant compound, C) Separating the resulting liquid extract from the solid residue, Characterised that the solution of step B substantially slows or halts the oxidative degradation of phenol acid compounds and retains the biological activity in the liquid extract, wherein the temperature during steps A)-C) does not exceed 38 degrees C. Suitable biological materials include Echinacea; Ginkgo Biloba; Kava Kava; Ginseng; Black Cohosh; Green Tea; St Johns Wort (with hypercerin as an active); Artichoke; Chamomile; Dong Quai; Grape Seed; Grape Skins; Hawthorn; Hops; Passion Flower; Pine Bark; Red Clover; Olive Leaf; currants; berries and a combination thereof.
Patent NZ-516632-A (NZ)
Title: Atlantic cod derived trypsins and chymotrypsins for topical application
Inventor: BJARNASON JON BRAGI
IPC: A01N37/18
Filed: 2000-06-15
Abstract: Fish derived serine proteases including trypsins and chymotrypsins derived from cod such as Atlantic cod are used for treating and/or preventing a variety of diseases and disorders such as inflammatory diseases, infectious diseases caused by viruses, bacteria and fungal species and diseases where a receptor binding mechanism is involved in the pathogenesis. Pharmaceutical and cosmetic compositions comprising the proteases are described.
Patent NZ-517950-A (NZ)
Title: Cover for aerobic treatment of biodegradable matter
Inventor: HOCHREIN KILIAN PETER
IPC: B09B3/00
Filed: 2000-09-21
Abstract: A cover for the contained aerobic treatment of biodegradable matter, especially for box composting of organic wastes, is described. The cover is a laminate of a porous polymeric layer adhered to a woven or knit or nonwoven fabric, in which the laminate has a specific air permeability and resistance to water vapor transmission (RET).
Patent NZ-518107-A (NZ)
Title: Preparation of metal complexes of amino acids obtained by hydrolysis of soy protein
Inventor: ANDERSON MICHAEL D
IPC: A23K1/16
Filed: 2002-04-02
Abstract: A process of preparing trace element/amino acid complexes from soy protein that can be used to produce mineral supplements, comprising; (a) blending soy isolate and soy concentrate wherein the amount of soy concentrate does not exceed 50 % by weight of the blend, (b) adding the blend slowly to acid heated to at least 70_C while agitating, (c) heating the acid/soy blend at temperatures between about 100_C and about 150_C for from 1 to 12 hours to hydrolyze the protein to single amino acid moieties, (d) reacting the single amino acid moieties with a soluble trace mineral source to form trace element/amino acid complexes.
Patent NZ-518309-A (NZ)
Title: Controlled release tolterodine formulation that releases not less than 80% of the active compound in under 18 hours
Inventor: NILVEBRANT LISBETH
IPC: A61K9/26
Filed: 2000-10-24
Abstract: Described is a pharmaceutical formulation containing tolterodine or a tolterodine-related compound, or a pharmacologically acceptable salt thereof, as active ingredient, in which the formulation exhibits a controlled in vitro release of the active ingredient in a phosphate buffer at pH 6.8 of not less than about 80% after 18 hours, and after oral administration to a patient is capable of maintaining a substantially constant serum level of the active moiety or moieties for 24 hours.  The use of the pharmaceutical formulation for treating overactive bladder, nocturia and gastrointestinal disorders is also described.
Patent NZ-522714-A (NZ)
Title: Centifuge and splitting blade for processing worms to extract essential fatty acids and protein
Inventor: LEWELLIN RICHARD LAURANCE
IPC: A22B5/20
Filed: 2002-11-21
Abstract: The apparatus and method for processing worms uses spaced top and bottom surfaces of a rotor set a sufficient distance apart so that worm bodies to be processed touch both surfaces.  A splitter is located mid-way between the surfaces and the worm bodies are forced by centrifugal force and by a flow of water in which the bodies are entrained to encounter and to be split by the splitter blade.  The top and bottom surfaces are set a sufficient distance apart so that the worm bodies are partially flattened when passing therebetween.  The splitter is located so as to be operative to split the central digestive tract of the worm body.  An inlet is located in the top surface through which the worm bodies are introduced into the space between the top and bottom surfaces.
Patent NZ-524116-A (NZ)
Title: Isozymes of lacrimator component synthase and gene encoding the same
Inventor: IMAI SHINSUKE
IPC: C07K14/415
Filed: 2001-08-30
Abstract: Disclosed are isozymes of the lachrymatory factor producing enzyme, the amino acid sequences of these isozymes and a gene that codes for these amino acid sequences. Particularly disclosed are three types of isozymes of the lachrymatory factor producing enzyme that contributes to the production of the lachrymatory factor that is present in onions and the like, amino acid sequences indicated by SEQ ID Nos. 1 to 3 which constitute the proteins or polypeptides of these isozymes, DNA indicated by SEQ ID Nos. 4 and 5 which contains base sequences that code for the abovementioned proteins or polypeptides. A method of producing the abovementioned isozymes, a recombinant vector which contains the abovementioned DNA, a transformant formed by transforming a host cell with the abovementioned recombinant vector, a method of producing proteins or polypeptides that have lachrymatory factor producing enzyme activity by culturing the abovementioned host cell, and anti-sense RNA which has a base sequence that is complementary to that of the mRNA corresponding to the abovementioned DNA are also disclosed.
Patent NZ-537162-A (NZ)
Title: Apparatus for determining the fineness of mineral fibers
Inventor: SEGHERS ALEX
IPC: G01N15/08
Filed: 2003-05-07
Abstract: Disclosed is a device for determining fineness of mineral fibers (1) adapted to supply the micronic value of fibers, said device (1) comprising a device for measuring (8) the fineness index, said fineness index measuring device (8) being provided with at least one first orifice (3) connected to a measuring cell (2) adapted to receive a sample consisting of a plurality of fibers and with a second orifice (6) connected to a device measuring (5) a differential pressure prevailing on either side of said sample, said differential pressure adjusting device (5) being designed to be connected to a fluid flow generating device (10). The fineness index measuring device (8) includes at least one volumetric flowmeter for the fluid passing through said cell (2).
Patent NZ-538290-A (NZ)
Title: Cyclonic fluid separator
Inventor: BETTING MARCO
IPC: B04C3/02
Filed: 2003-09-02
Abstract: A cyclonic fluid separator for separating condensable, liquid and/or solid components from a fluid mixture is disclosed. The separator includes an upstream fluid inlet section in which the fluid mixture is accelerated to a supersonic velocity to expand and cool the fluid mixture so that one or more condensable fluid components are liquefied and/or solidified, a downstream separation section in which condensables depleted and condensables enriched fluid fractions are separated and fed into separate outlets, and a midstream vortex generation section which has multiple tilted wings. The tips 5A,5B of the wings are located at relatively large mutual spacings D and at a small spacing S<0.2W from the inner wall of the midstream vortex generation section so that during normal operation of the separator adjacent to the various wing tips widely spaced vortices 6A,6B of swirling fluid are generated in the fluid stream flowing through the housing. The vortices 6A,6B are still separated from each other at the entrance of the downstream separation section.
Patent NZ-545579-A (NZ)
Title: Gamma d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
Inventor: HORVATH STEPHANE
Filed: 2006-02-27
Abstract: Disclosed is a gamma d-crystalline form of ivabradine hydrochloride of formula (I) characterised by the powder X-ray diffraction diagram as described in the specification. Also disclosed are processes for the preparation of said crystalline form; pharmaceutical compositions containing said crystalline form; and the use of said crystalline form as a bradycardic, in particular for the treatment of various clinical situations of myocardial ischaemia.
Patent NZ-547085-A (NZ)
Title: Proteins
Inventor: KELLET-SMITH ANJA HEMMINGSEN
IPC: A23L15/00
Filed: 2004-12-23
Abstract: Provided is a method of producing a variant glycolipid acyltransferase enzyme comprising selecting a parent enzyme which is a lipid acyltransferase enzyme wherein the enzyme comprises the amino acid sequence motif GDSX, wherein X is one or more of the following amino acid residues L, A, V, I, F, Y, H, Q, T, N, M or S and modifying one or more amino acids to produce a variant lipid acyltransferase, aided by structural homology mapping and inclusion of specified amino acid changes compared to wildtype sequence. Further provided are methods of using the enzymes in food processing, e.g. enzymatic degumming of vegetables of edible oils.
Patent NZ-549100-A (NZ)
Title: Crystalline composition containing escitalopram oxalate
Inventor: JENSEN KIM BOJSTRUP
IPC: C07D307/87
Filed: 2005-02-21
Abstract: The present invention discloses crystalline particles of escitalopram oxalate which either have a median particle size of at least 20 micrometres or comprise at least 0.01 % (w/w) of E- or Z-4-(4-dimethylamino-1-(4-fluorophenyl)-but-1-enyl)-3-hydroxymethyl-benzonitrile, said particles being suitable for use in direct compression, wet or dry or melt granulation. Furthermore, the invention discloses a novel pharmaceutical unit dosage form containing such crystalline particles of escitalopram oxalate as well as methods for manufacture of such crystalline particles of escitalopram oxalate. Finally, the invention provides a method for reduction of the amount of hydroxyl containing impurities in a solution of citalopram or escitalopram.
Patent NZ-552547-A (NZ)
Title: Production of Delta 9 tetrahydrocannabinol from plant material
Inventor: GOODWIN NEIL JOHN
IPC: A61P1/08
Filed: 2003-02-03
Abstract: Disclosed is a method of purification of delta 9 tetrahydrocannabinol comprising charcoal filtration of a delta 9 THC containing composition, delta 9 THC comprising less than 0.5% cannabinol and its use in pharmaceutical compositions. (62) (62) Divided out of 534430
Patent NZ-552641-A (NZ)
Title: Barbed sutures
Inventor: LEUNG JEFFERY C
IPC: A61B17/04
Filed: 2003-09-29
Abstract: A barbed suture for connecting tissue. The suture includes an elongated body and a plurality of barbs projecting from the body. Each barb causes the suture to resist movement in an opposite direction from which the barb faces. The disposition of the barbs on the body is an overlapping disposition such that for at least two adjacent barbs, one being an overlapping barb and one being an overlapped barb, the overlapping barb has an underside (US) and the overlapped barb has a topside (TS) where part of the underside (US) of the overlapping barb is derived from part of and the topside (TS) of the overlapped barb.
Patent NZ-554128-A (NZ)
Title: Releasable toilet seat hinge assembly using bayonet type coupling to removably attach hinge with seat/cover
Inventor: VIERKANT ERICH C
IPC: A47K13/26
Filed: 2005-09-19
Abstract: A hinge assembly is provided for connecting a toilet seat and cover to a rearward extension behind a toilet bowl. A base member (20) is permanently affixed to the extension. A hinge support member (14) is rotatably linked to the base member in bayonet connection fashion. The hinge support member, seat and cover can be removed from the toilet bowl, leaving only the base member attached to the extension.
Patent NZ-554361-A (NZ)
Title: Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
Inventor: KOMPELLA AMALA KISHAN
Filed: 2005-07-19
Abstract: Disclosed is a phenyl amino pyrido pyrimidine of formula I where X is CH or N, n=1 or 2, R is H or CH3; or a pharmaceutically acceptable salt thereof. Also disclosed is the use of the above compound for treating a proliferative disorder.
Patent NZ-568746-A (NZ)
Title: Syringe and optical reader
Inventor: KLEIN CORNELIS KEES
IPC: A61M5/178
Filed: 2005-11-29
Abstract: An optical reader (120) adapted to couple to a liquid delivery device with a reservoir and generate position data indicative of the position of a liquid delivery means of the liquid delivery device, the optical reader comprising: a coupling (122a, 122b, 123a, 123b, 124a, 124b) to couple the reader to a liquid delivery device, at least one optical detector arranged to detect optically readable markings on a liquid delivery means, each optical detector adapted to provide an output signal indicative of one or more detected optically readable markings, and a processor coupled to receive the output signal and generate position data indicating the position of the liquid dispensing means relative to the reservoir. A liquid delivery device including an optical reader is also disclosed.
Patent NZ-572807-A (NZ)
Title: Culture method for obtaining a clonal population of antigen-specific b cells
Inventor: GARCIA LEON
IPC: C12N5/16
Filed: 2007-05-21
Abstract: Disclosed is a method of identifying a B cell that expresses an antibody specific to a desired antigen. The disclosed method comprises: a) enriching a heterogeneous population of B cells including B cells that secrete an antibody specific to a desired antigen to increase the proportion of B cells that secrete antibodies specific for said antigen, thereby forming an enriched B cell population; b) culturing one or more sub-populations of cells from said enriched B cell population; c) determining whether said cultured sub-populations produce an antibody specific to said antigen, thereby identifying one or more antigen-positive sub-populations; and d) determining whether an individual B cell produces an antibody specific to the antigen by a method comprising: 1) isolating one or more individual B cells from one or more of said antigen-positive sub-populations of step (c); 2) providing an immobilised antigen comprising a matrix or solid support to which said antigen has been directly or indirectly attached; 3) incubating one of said isolated individual B cells of (d)(1) or the progeny thereof with said immobilised antigen; 4) detecting whether an antibody secreted by said individual B cell is bound to said immobilised antigen; and 5) identifying a B cell that expresses an antibody specific to said antigen by its being adjacent to detected antibodies secreted by said individual B cell which are bound to said immobilised antigen.
Patent NZ-579503-A (NZ)
Title: Child resistant closure for a tap
Inventor: SMITH MARK A
IPC: F16K31/50
Filed: 2008-03-03
Abstract: A tap assembly 10 comprising a valve body 14 with a first wall defining a valve chamber, the first wall having a pair of opposed tracks extending axially along an inner surface of the first wall, and a fluid exit 20, and a tap handle 12 mounted to the valve body 14 for rotational movement of the tap handle 12 with respect to the first wall. The tap handle 12 has a second wall defining an annular chamber supporting a set of threads, and a generally tubular valve stem 16 having a first end and an opposed second end. The first end of the valve stem 16 has a pair of lugs 56 circumferentially spaced from one another, the lugs being positioned within the threads, and the second end of the valve stem 16 extends into the valve chamber. The valve stem 16 is responsive to movement of the tap handle 12 to move from a first position where the fluid exit 20 is sealed by the second end of the valve stem 16 to a second position where the fluid exit 20 is not sealed by the second end of the valve stem 16 and fluid is allowed to flow through the fluid exit 20.
Patent NZ-588439-A (NZ)
Title: Novel aminomethyl benzene derivatives
Inventor: BOLLI MARTIN
IPC: A61P37/00
Filed: 2009-03-03
Abstract: Disclosed are aminomethyl benzene compounds of formula (I) or salts thereof, wherein the substituents are as defined in the specification, pharmaceutical compositions comprising said compounds and their use for the prevention or treatment of diseases or disorders associated with an activated immune system such as rejection of transplanted organs, automimmune syndromes, inflammatory bowel diseases and solid cancers.
Patent NZ-591818-A (NZ)
Title: Processes for the preparation of sglt2 inhibitors
Inventor: LIOU JASON
IPC: A61P3/00
Filed: 2009-08-21
Abstract: 591818 Disclosed is a method for producing a complex of formula IA which is an amino acid salt of a pyran. The method includes reacting the precursor with a reducing agent in the presence of an activating group to form the compound and then reacting it with an amino acid to form the complex of formula IA. Examples of the compounds are: (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(2-(2,2,2- trifluoroethoxy)ethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(2-(cyclohex-2-enyloxy)ethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; and (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((E)-3-cyclopropylallyloxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol complexed with proline or phenylalanine.
Patent NZ-592420-A (NZ)
Title: Cd86 antagonist multi-target binding proteins
Inventor: THOMPSON PETER ARMSTRONG
IPC: C07K16/28
Filed: 2009-10-02
Abstract: This disclosure provides a multi-specific fusion protein composed of a CD86 antagonist binding domain and another binding domain that is an IL-10 agonist. The multi-specific fusion protein may also include an intervening domain that separates the other domains. This disclosure also provides polynucleotides encoding the multi-specific fusion proteins, compositions of the fusion proteins, and methods of using the multi-specific fusion proteins and compositions.
Patent NZ-597217-A (NZ)
Title: Quantitative and self-calibrating chemical analysis using paper-based microfluidic systems
Inventor: SHEN WEI
IPC: G01N33/48
Filed: 2010-06-30
Abstract: A method of determining the concentration of a test fluid sample using a paper-based microfluidic system having a plurality of hydrophilic testing zones, including: a) depositing said test fluid sample on at least one said testing zone; b) depositing a plurality of standard fluid samples or reactives of differing known concentrations on other said testing zones; c) introducing an indicator solution to each said test zone to thereby react with the deposited fluid sample and result in a colour intensity change which is a function of the fluid sample concentration; and d) comparing the differences in colour intensity between the test fluid sample and the standard fluid samples or reactives to thereby determine the concentration of said test fluid sample. It is therefore an object of the present disclosure to more accurately determine the concentration of a test sample using paper-based microfluidic systems. the sample volume amount can be significantly reduced which is helpful when the obtained sample amount is limited (example a biological sample from a hospital patient). It should be noted that the term  paper  is used in the application to refer to cellulosic material including woven fabrics and nonwoven material in addition to paper. The use of a plurality of standard fluid samples or reactives of different known concentrations provides an internal self-calibration for the method according to the present invention. This can lead to more accurate results being obtained notwithstanding various external factors.